Oral mucositis is the inflammation of the oral mucosa that occurs as a side effect of cytotoxic cancer therapy. Though the condition cannot be prevented, steps can be taken to decrease the severity and for the desired therapeutic outcome of cancer therapy. The communication between the oncologist and dentist becomes vital for the patient benefit. A search of the resources through Medline and Google Scholar was made to comprehend the pathobiology, clinical characteristics, and various therapeutic methods related to oral mucositis. A total of 63 articles were chosen for reference, which mostly includes recent year review papers. After the final screening, 29 research papers were selected for the current study. Controlling the predisposing risk factors pertaining to the oral cavity and recording the baseline oral health status before the commencement of cancer therapy is crucial. Patients are counseled for proper oral hygiene routine, and lifelong follow-up.
Sroussi HY, Epstein JB, Bensadoun RJ, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 2017;6(12):2918–2931. DOI: 10.1002/cam4.1221.
White S, Pharoah M. Oral radiology: principles and interpretation, 7th ed. St. Louis: Elsevier; 2014.
Vera-Llonch M, Oster G, Ford CM, et al. Oral mucositis and outcomes of allogenic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 2007;15(5):491–496. DOI: 10.1007/s00520-006-0176-9.
Vera-Llonch M, Oster G, Hagiwara M, et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006;106(2):329–336. DOI: 10.1002/cncr.21622.
Forman SJ, Negrin RS, Antin JH, et al. Thomas' Hematopoietic Cell Transplantation. Hoboken, United Kingdom: John Wiley & Sons, Incorporated; 2015.
Squier C, Brogden K. Human oral mucosa. Chichester, West Sussex, U.K.: Wiley-Blackwell; 2011.
Sonis S. A biological approach to mucositis. J Support Oncol 2003;2(1):21–32.
Vissink A, Jansma J, Spijkervet FKL, et al. Oral Sequelae of Head and Neck Radiotherapy. Crit Rev Oral Biol Med 2003;14(3):199–212. DOI: 10.1177/154411130301400305.
Chaveli-López B, Bagán-Sebastián JV. Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent 2016;8(2):201–209. DOI: 10.4317/jced.52917.
Elting LS, Cooksley CD, Chambers MS, et al. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007;68(4):1110–1120. DOI: 10.1016/j.ijrobp.2007.01.053.
Elting LS, Coakley C, Chambers M, et al. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98(7):1531–1539. DOI: 10.1002/cncr.11671.
Bloomer WD, Hellman S. Normal tissue responses to radiation therapy. N Engl J Med 1975;293(2):80–83. DOI: 10.1056/NEJM197507102930206.
Donnelly JP, Bellm LA, Epstein JB, et al. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003;3(7):405–412. DOI: 10.1016/S1473-3099(03)00668-6.
Sonis S. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 2007;5(9 Suppl 4):3–11.
Jensen S, Pedersen A, Reibel J, et al. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 2003;11(4):207–225. DOI: 10.1007/s00520-002-0407-7.
Jose-Louis P, Andres A, Philippe N. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 1998;3(6):446–451.
Lustberg M. Management of neutropenia in cancer patients. Clin Adv Hematol Oncol 2012;10(12):825–826.
Van Der Velden W, Herbers A, Netea M, et al. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 2014;167(4):441–452. DOI: 10.1111/bjh.13113.
Kaufman RM, Anderson KC. Causes of Pancytopenia. Holland-Frei Cancer Medicine, 6th ed. Hamilton (ON): BC Decker; 2003.
BC Cancer Agency. Symptom Management Guidelines: Oral mucositis. [Internet]. 2019 [cited 27 April 2019]. Available from: http://www.bccancer.bc.ca/nursing site/Documents/12.%20Oral%20Mucositis.pdf.
Ziętarska M, Krawczyk-Lipiec J, Kraj L, et al. Chemotherapy-related toxicity, nutritional status and quality of life in precachectic oncologic patients with, or without, high protein nutritional support. A prospective, randomized study. Nutrients 2017;9(10):E1108. DOI: 10.3390/nu9101108.
Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001;29:7–15. DOI: 10.1093/oxfordjournals.jncimonographs.a003443.
Treister NS, Chemotherapy-Induced Oral Mucositis [Internet]. 2017. Available from: https://emedicine.medscape.com/article/1079570-overview.
Springer IN, Niehoff P, Warnke PH, et al. Radiation caries – radiogenic destruction of dental collagen. Oral Oncol 2005;41(7):723–728. DOI: 10.1016/j.oraloncology.2005.03.011.
McComb D, Erickson RL, Maxymiw WG, et al. A clinical comparison of glass ionomer, resin-modified glass ionomer and resin composite restorations in the treatment of cervical caries in xerostomic head and neck radiation patients. Oper Dent 2002;27(5):430–437.
Hu JY, Li YQ, Smales RJ, et al. Restoration of teeth with more-viscous glass ionomer cements following radiation-induced caries. Int Dent J 2002;52(6):445–448. DOI: 10.1111/j.1875-595X.2002.tb00640.x.
Peterson DE, Jensen SB. Oral complications of nonsurgical cancer therapies: diagnosis and treatment. In: Glick M, ed. Burket's Oral Medicine, 12th ed. People's Medical Publishing House; 2014. pp. 201–218.
Lalla R, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2014;120(10):1453–1461. DOI: 10.1002/cncr. 28592.
Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg 2013;32(1):41–52.
Lin P, Sermersheim M, Li H, et al. Zinc in wound healing modulation. Nutrients 2017;10(1):E16. DOI: 10.3390/nu10010016.
Nooka A, Johnson H, Kaufman J, et al. Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014;20(6):852–857. DOI: 10.1016/j.bbmt.2014.02.025.
Yagiela J, Dowd F, Johnson B, et al. Pharmacology and therapeutics for dentistry, 6th ed. Elsevier Health Sciences; 2010. pp. 735–750.
Katsura K, Sasai K, Sato M, et al. Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(6):731–738. DOI: 10.1016/j.tripleo.2007.10.011.
Epstein JB, Lunn R, Le N, et al. Periodontal attachment loss in patients after head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86(6):673–677. DOI: 10.1016/S1079-2104(98)90202-5.
Preshaw PM, Hefti AF, Jepsen S, et al. Subantimicrobial dose doxycycline as an adjunctive treatment for periodontitis. A review. J Clin Periodontol 2004;31(9):697–707. DOI: 10.1111/j.1600-051X.2004.00558.x.